Diabetes Metab J.  2012 Dec;36(6):422-432. 10.4093/dmj.2012.36.6.422.

Prevalence of Type 2 Diabetes and Impaired Glucose Regulation with Associated Cardiometabolic Risk Factors and Depression in an Urbanizing Rural Community in Bangladesh: A Population-Based Cross-Sectional Study

Affiliations
  • 1Department of Community Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway. doctorbiplob@gmail.com
  • 2Executive Diabetes Care Centre, NHN, Diabetic Association of Bangladesh, Dhaka, Bangladesh.
  • 3Department of Biochemistry & Cell Biology, Bio-Medical Research Group, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka, Bangladesh.
  • 4Diabetes Prevention Intervention Project, Diabetic Association of Bangladesh, Dhaka, Bangladesh.
  • 5Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh.
  • 6Department of Endocrinology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka, Bangladesh.

Abstract

BACKGROUND
To determine the prevalence of type 2 diabetes (T2DM) and impaired glucose regulation (impaired fasting glucose [IFG] and impaired glucose tolerance [IGT]) in an urbanizing rural population of Bangladesh and associated cardiometabolic risk indicators and depression.
METHODS
A total of 2,293 subjects aged > or =20 years in an urbanizing rural Bangladeshi community were investigated. Socio-demographic and anthropometric details, blood pressure, fasting plasma glucose (FPG), 2 hours after 75 g plasma glucose (2hPG), glycosylated hemoglobin, fasting serum insulin and lipid profiles were studied. Presence of depressive symptoms using Montogomery-Asberg Depression Rating Scale was also assessed.
RESULTS
The prevalence of IFG, IGT, IFG+IGT, and T2DM were 3.4%, 4.0%, 1.2%, and 7.9%, respectively. The prevalence of T2DM and impaired glucose regulation differed between males and females, but, both increased with age in both sexes. FPG and 2hPG had positive correlation. Employing logistic regression, it was found that increased age, waist to hip ratio, systolic blood pressure, total cholesterol, triglycerides, and depression were independent risk indicators for diabetes. Both insulin resistance and beta-cell deficiency were significantly related for causation of diabetes. Among the study population, 26.2% had general obesity, 39.8% central obesity, 15.5% hypertension, 28.7% dyslipidemia, 17.6% family history of diabetes, and 15.3% had depression. Physical inactivity and smoking habits were significantly higher in male.
CONCLUSION
Rising prevalence of diabetes and impaired glucose regulation in this urbanizing rural population exist as a significant but hidden public health problem. Depression and other cardiometabolic risk indicators including obesity, hypertension, and dyslipdemia were also prevalent in this population.

Keyword

Bangladesh; Diabetes mellitus; Impaired glucose regulation; Prevalence

MeSH Terms

Aged
Bangladesh
Blood Pressure
Cholesterol
Cross-Sectional Studies
Depression
Diabetes Mellitus
Dyslipidemias
Fasting
Female
Glucose
Hemoglobin A, Glycosylated
Humans
Hypertension
Insulin
Insulin Resistance
Logistic Models
Male
Obesity
Obesity, Abdominal
Plasma
Prevalence
Public Health
Risk Factors
Rural Population
Smoke
Smoking
Triglycerides
Waist-Hip Ratio
Cholesterol
Glucose
Hemoglobin A, Glycosylated
Insulin
Smoke
Triglycerides

Cited by  1 articles

Moderate diet-induced weight loss is associated with improved insulin sensitivity in middle-aged healthy obese Korean women
Hye-Ok Lee, Jung-Eun Yim, Young-Seol Kim, Ryowon Choue
Nutr Res Pract. 2014;8(4):469-475.    doi: 10.4162/nrp.2014.8.4.469.


Reference

1. International Diabetes Federation: Diabetes atlas. cited 2011 Sep 30. Available from: http://www.idf.org/atlasmap/atlasmap.
2. World Health Organization: Diabetes programme. cited 2011 Sep 30. Available from: http://www.who.int/diabetes/en/.
3. National Institute of Diabetes and Digestive and Kidney Diseases (US) Office of Behavioral and Social Sciences Research. Centers for Disease Control and Prevention (US) Public Health Practice Program Office Division of Diabetes Translation. From clinical trials to community: the science of translating diabetes and obesity research. 2004. Bethesda: National Institutes of Health;49–52. Translating the diabetes prevention program.
4. National Institute of Diabetes and Digestive and Kidney Diseases (US) Office of Behavioral and Social Sciences Research. Centers for Disease Control and Prevention (US) Public Health Practice Program Office Division of Diabetes Translation. From clinical trials to community: the science of translating diabetes and obesity research. 2004. Bethesda: National Institutes of Health;53–55. Translating obesity and diabetes research: some challenges and recommendations.
5. Central Intelligence Agency: The world factbook. updated 2012 Oct 4. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/bg.html.
6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004. 27:1047–1053.
7. Ramachandran A, Snehalatha C, Latha E, Manoharan M, Vijay V. Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res Clin Pract. 1999. 44:207–213.
8. Rahim MA, Hussain A, Azad Khan AK, Sayeed MA, Keramat Ali SM, Vaaler S. Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Diabetes Res Clin Pract. 2007. 77:300–305.
9. Sayeed MA, Mahtab H, Akter Khanam P, Abdul Latif Z, Keramat Ali SM, Banu A, Ahren B, Azad Khan AK. Diabetes and impaired fasting glycemia in a rural population of Bangladesh. Diabetes Care. 2003. 26:1034–1039.
10. Rahim MA, Azad Khan AK, Nahar Q, Ali SM, Hussain A. Impaired fasting glucose and impaired glucose tolerance in rural population of Bangladesh. Bangladesh Med Res Counc Bull. 2010. 36:47–51.
11. World Health Organization, Department of Noncommunicable Disease Surveillance. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. 1999. Geneva: World Health Organization.
12. Hussain A, Rahim MA, Azad Khan AK, Ali SM, Vaaler S. Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh. Diabet Med. 2005. 22:931–936.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985. 28:412–419.
14. Choo V. WHO reassesses appropriate body-mass index for Asian populations. Lancet. 2002. 360:235.
15. World Health Organization Regional Office for the Western Pacific. International Association for the Study of Obesity. International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. 2000. Sydney: Health Communications Australia.
16. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999. 17:151–183.
17. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979. 134:382–389.
18. Zahid N, Asghar S, Claussen B, Hussain A. Depression and diabetes in a rural community in Pakistan. Diabetes Res Clin Pract. 2008. 79:124–127.
19. Bangladesh Bureau of Statistics. Statistical pocket book of Bangladesh. 2001. Dacca: Statistical Division, Ministry of Planning.
20. Sayeed MA, Hussain MZ, Banu A, Rumi MA, Azad Khan AK. Prevalence of diabetes in a suburban population of Bangladesh. Diabetes Res Clin Pract. 1997. 34:149–155.
21. Hussain A, Vaaler S, Sayeed MA, Mahtab H, Ali SM, Khan AK. Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population-based study. Eur J Public Health. 2007. 17:291–296.
22. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia. 1997. 40:232–237.
23. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, Bastar I, Tutuncu Y, Sargin M, Dinccag N, Karsidag K, Kalaca S, Ozcan C, King H. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002. 25:1551–1556.
24. Zahid N, Claussen B, Hussain A. Diabetes and impaired glucose tolerance in a rural area in Pakistan and associated risk factors. Diabetes Metab Syndr Clin Res Rev. 2008. 2:125–130.
25. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KG. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care. 1999. 22:399–402.
26. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998. 21:518–524.
27. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000. 23:1108–1112.
28. de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care. 1998. 21:1686–1690.
29. Yliharsila H, Lindstrom J, Eriksson JG, Jousilahti P, Valle TT, Sundvall J, Tuomilehto J. Prevalence of diabetes and impaired glucose regulation in 45- to 64-year-old individuals in three areas of Finland. Diabet Med. 2005. 22:88–91.
30. Ramachandran A, Snehalatha C, Satyavani K, Vijay V. Impaired fasting glucose and impaired glucose tolerance in urban population in India. Diabet Med. 2003. 20:220–224.
31. McNeely MJ, Boyko EJ. Type 2 diabetes prevalence in Asian Americans: results of a national health survey. Diabetes Care. 2004. 27:66–69.
32. Ramachandran A, Snehalatha C, Latha E, Vijay V. Evaluation of the use of fasting plasma glucose as a new diagnostic criterion for diabetes in Asian Indian population. Diabetes Care. 1998. 21:666–667.
33. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, Dwyer T, Colagiuri S, Jolley D, Knuiman M, Atkins R, Shaw JE. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care. 2002. 25:829–834.
34. Roy MN, Biswas KB, Siddiqua N, Arslan MI, Ali L. Determinants of insulin secretion and sensitivity in bangladeshi type 2 diabetic subjects. Metab Syndr Relat Disord. 2007. 5:275–281.
35. Hossain M, Kabir G, Hasan N, Faruque O, Sikdar D, Alauddin M, Ali L. Metabolic syndrome of prediabetic and diabetic subjects in a Bangladeshi population. Diabetes Metab Syndr Clin Res Rev. 2009. 3:233–236.
36. Groop LC. Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes Metab. 1999. 1:Suppl 1. S1–S7.
37. Pickup JC, Williams G. Chapter 21, Obesity and nutritional factors in the pathogenesis of type 2 diabetes mellitus. Textbook of diabetes. 2002. 3rd ed. London: Blackwell Scientific Publications;21.1–21.16.
38. Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007. 116:1942–1951.
39. Abu Sayeed M, Banu A, Khan AR, Hussain MZ. Prevalence of diabetes and hypertension in a rural population of Bangladesh. Diabetes Care. 1995. 18:555–558.
40. Asghar S, Hussain A, Ali SM, Khan AK, Magnusson A. Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet Med. 2007. 24:872–877.
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr